Skip to main content
Top
Published in: Diabetologia 9/2012

01-09-2012 | Article

No evidence of enteroviruses in the intestine of patients with type 1 diabetes

Authors: A. Mercalli, V. Lampasona, K. Klingel, L. Albarello, C. Lombardoni, J. Ekström, V. Sordi, A. Bolla, A. Mariani, D. Bzhalava, J. Dillner, M. Roivainen, E. Bosi, L. Piemonti

Published in: Diabetologia | Issue 9/2012

Login to get access

Abstract

Aims/hypothesis

The purpose of this study was to investigate whether the gut mucosa is a reservoir for enterovirus persistence in patients with type 1 diabetes.

Methods

Small intestine biopsy samples from 25 individuals at different stages of type 1 diabetes, 21 control individuals and 27 individuals with coeliac disease were analysed for the presence of enterovirus RNA by using both radioactive in-situ hybridisation and real-time RT-PCR and for the presence of enterovirus proteins by immunostaining with antibodies against VP1 and VP4-2-3 capsid proteins and virus polymerase. Lymphocytic enteropathy and serum anti-VP1 antibodies were also evaluated at the time of biopsy. Moreover, high-throughput sequencing was performed to identify viral transcripts or genomes.

Results

Enterovirus was not detected by in-situ hybridisation or RT-PCR in any of the individuals tested. Immunohistology revealed a few stained cells in the intestinal epithelium in a low number of individuals, with no difference between diabetic and non-diabetic individuals. Levels of serum IgG against VP1 did not differ between control individuals and those with diabetes or coeliac disease and no evidence of diabetes-related lymphocytic enteropathy was detected. High-throughput sequencing did not reveal specific enterovirus sequences in the gut mucosa of individuals with type 1 diabetes.

Conclusions/interpretation

Prolonged/persistent enterovirus infections in gut mucosa are not common in patients with type 1 diabetes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Oikarinen M, Tauriainen S, Oikarinen S et al (2012) Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 61:687–691PubMedCrossRef Oikarinen M, Tauriainen S, Oikarinen S et al (2012) Type 1 diabetes is associated with enterovirus infection in gut mucosa. Diabetes 61:687–691PubMedCrossRef
2.
go back to reference Simonen-Tikka ML, Pflueger M, Klemola P et al (2011) Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 54:2995–3002PubMedCrossRef Simonen-Tikka ML, Pflueger M, Klemola P et al (2011) Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study. Diabetologia 54:2995–3002PubMedCrossRef
3.
go back to reference Smura T, Ylipaasto P, Klemola P et al (2010) Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol 82:1940–1949PubMedCrossRef Smura T, Ylipaasto P, Klemola P et al (2010) Cellular tropism of human enterovirus D species serotypes EV-94, EV-70, and EV-68 in vitro: implications for pathogenesis. J Med Virol 82:1940–1949PubMedCrossRef
4.
go back to reference Stene LC, Oikarinen S, Hyoty H et al (2010) Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59:3174–3180PubMedCrossRef Stene LC, Oikarinen S, Hyoty H et al (2010) Enterovirus infection and progression from islet autoimmunity to type 1 diabetes: the Diabetes and Autoimmunity Study in the Young (DAISY). Diabetes 59:3174–3180PubMedCrossRef
5.
go back to reference Tapia G, Cinek O, Rasmussen T et al (2011) Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 34:151–155PubMedCrossRef Tapia G, Cinek O, Rasmussen T et al (2011) Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study. Diabetes Care 34:151–155PubMedCrossRef
6.
go back to reference Witso E, Tapia G, Cinek O, Pociot FM, Stene LC, Ronningen KS (2011) Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity. PLoS One 6:e27781PubMedCrossRef Witso E, Tapia G, Cinek O, Pociot FM, Stene LC, Ronningen KS (2011) Polymorphisms in the innate immune IFIH1 gene, frequency of enterovirus in monthly fecal samples during infancy, and islet autoimmunity. PLoS One 6:e27781PubMedCrossRef
7.
go back to reference Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35PubMedCrossRef Yeung WC, Rawlinson WD, Craig ME (2011) Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies. BMJ 342:d35PubMedCrossRef
8.
9.
go back to reference Lindberg B, Ahlfors K, Carlsson A et al (1999) Previous exposure to measles, mumps, and rubella—but not vaccination during adolescence—correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics 104:e12PubMedCrossRef Lindberg B, Ahlfors K, Carlsson A et al (1999) Previous exposure to measles, mumps, and rubella—but not vaccination during adolescence—correlates to the prevalence of pancreatic and thyroid autoantibodies. Pediatrics 104:e12PubMedCrossRef
10.
go back to reference Banatvala JE, Bryant J, Schernthaner G et al (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1:1409–1412PubMedCrossRef Banatvala JE, Bryant J, Schernthaner G et al (1985) Coxsackie B, mumps, rubella, and cytomegalovirus specific IgM responses in patients with juvenile-onset insulin-dependent diabetes mellitus in Britain, Austria, and Australia. Lancet 1:1409–1412PubMedCrossRef
11.
go back to reference Ratzmann KP (1986) Autoimmunity and the development of diabetes mellitus in relation to mumps infection. Diabetologia 29:673–674PubMedCrossRef Ratzmann KP (1986) Autoimmunity and the development of diabetes mellitus in relation to mumps infection. Diabetologia 29:673–674PubMedCrossRef
12.
go back to reference Ballotti S, de Martino M (2007) Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J Pediatr Gastroenterol Nutr 45:147–156PubMedCrossRef Ballotti S, de Martino M (2007) Rotavirus infections and development of type 1 diabetes: an evasive conundrum. J Pediatr Gastroenterol Nutr 45:147–156PubMedCrossRef
13.
go back to reference Makela M, Oling V, Marttila J et al (2006) Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes. Clin Exp Immunol 145:261–270PubMedCrossRef Makela M, Oling V, Marttila J et al (2006) Rotavirus-specific T cell responses and cytokine mRNA expression in children with diabetes-associated autoantibodies and type 1 diabetes. Clin Exp Immunol 145:261–270PubMedCrossRef
14.
go back to reference Makela M, Vaarala O, Hermann R et al (2006) Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 27:54–61PubMedCrossRef Makela M, Vaarala O, Hermann R et al (2006) Enteral virus infections in early childhood and an enhanced type 1 diabetes-associated antibody response to dietary insulin. J Autoimmun 27:54–61PubMedCrossRef
15.
go back to reference Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J (2008) Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 51:769–772PubMedCrossRef Aarnisalo J, Veijola R, Vainionpaa R, Simell O, Knip M, Ilonen J (2008) Cytomegalovirus infection in early infancy: risk of induction and progression of autoimmunity associated with type 1 diabetes. Diabetologia 51:769–772PubMedCrossRef
16.
go back to reference Krause I, Anaya JM, Fraser A et al (2009) Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 1173:633–639PubMedCrossRef Krause I, Anaya JM, Fraser A et al (2009) Anti-infectious antibodies and autoimmune-associated autoantibodies in patients with type I diabetes mellitus and their close family members. Ann N Y Acad Sci 1173:633–639PubMedCrossRef
17.
go back to reference Smelt MJ, Faas MM, de Haan BJ et al (2012) Susceptibility of human pancreatic beta cells for cytomegalovirus infection and the effects on cellular immunogenicity. Pancreas 41:39–49PubMedCrossRef Smelt MJ, Faas MM, de Haan BJ et al (2012) Susceptibility of human pancreatic beta cells for cytomegalovirus infection and the effects on cellular immunogenicity. Pancreas 41:39–49PubMedCrossRef
18.
go back to reference von Herrath M, Filippi C, Coppieters K (2011) How viral infections enhance or prevent type 1 diabetes—from mouse to man. J Med Virol 83:1672CrossRef von Herrath M, Filippi C, Coppieters K (2011) How viral infections enhance or prevent type 1 diabetes—from mouse to man. J Med Virol 83:1672CrossRef
19.
go back to reference Oikarinen M, Tauriainen S, Honkanen T et al (2008) Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 151:71–75PubMedCrossRef Oikarinen M, Tauriainen S, Honkanen T et al (2008) Detection of enteroviruses in the intestine of type 1 diabetic patients. Clin Exp Immunol 151:71–75PubMedCrossRef
20.
go back to reference Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef Chomczynski P, Sacchi N (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156–159PubMedCrossRef
21.
go back to reference Pillet S, Billaud G, Omar S, Lina B, Pozzetto B, Schuffenecker I (2010) Multicenter evaluation of the ENTEROVIRUS R-gene real-time RT-PCR assay for the detection of enteroviruses in clinical specimens. J Clin Virol 47:54–59PubMedCrossRef Pillet S, Billaud G, Omar S, Lina B, Pozzetto B, Schuffenecker I (2010) Multicenter evaluation of the ENTEROVIRUS R-gene real-time RT-PCR assay for the detection of enteroviruses in clinical specimens. J Clin Virol 47:54–59PubMedCrossRef
22.
go back to reference Klingel K, Hohenadl C, Canu A et al (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89:314–318PubMedCrossRef Klingel K, Hohenadl C, Canu A et al (1992) Ongoing enterovirus-induced myocarditis is associated with persistent heart muscle infection: quantitative analysis of virus replication, tissue damage, and inflammation. Proc Natl Acad Sci U S A 89:314–318PubMedCrossRef
23.
go back to reference Werner S, Klump WM, Schonke H, Hofschneider PH, Kandolf R (1988) Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA 7:307–316PubMedCrossRef Werner S, Klump WM, Schonke H, Hofschneider PH, Kandolf R (1988) Expression of coxsackievirus B3 capsid proteins in Escherichia coli and generation of virus-specific antisera. DNA 7:307–316PubMedCrossRef
24.
go back to reference Burbelo PD, Hoshino Y, Leahy H et al (2009) Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol 16:366–371PubMedCrossRef Burbelo PD, Hoshino Y, Leahy H et al (2009) Serological diagnosis of human herpes simplex virus type 1 and 2 infections by luciferase immunoprecipitation system assay. Clin Vaccine Immunol 16:366–371PubMedCrossRef
25.
go back to reference Arnheim Dahlstrom L, Andersson K, Luostarinen T et al (2011) Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev 20:2541–2550PubMedCrossRef Arnheim Dahlstrom L, Andersson K, Luostarinen T et al (2011) Prospective seroepidemiologic study of human papillomavirus and other risk factors in cervical cancer. Cancer Epidemiol Biomarkers Prev 20:2541–2550PubMedCrossRef
26.
go back to reference Roivainen M, Klingel K (2010) Virus infections and type 1 diabetes risk. Curr Diab Rep 10:350–356PubMedCrossRef Roivainen M, Klingel K (2010) Virus infections and type 1 diabetes risk. Curr Diab Rep 10:350–356PubMedCrossRef
27.
go back to reference Roivainen M, Klingel K (2009) Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52:995–996PubMedCrossRef Roivainen M, Klingel K (2009) Role of enteroviruses in the pathogenesis of type 1 diabetes. Diabetologia 52:995–996PubMedCrossRef
28.
go back to reference Ylipaasto P, Klingel K, Lindberg AM et al (2004) Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47:225–239PubMedCrossRef Ylipaasto P, Klingel K, Lindberg AM et al (2004) Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells. Diabetologia 47:225–239PubMedCrossRef
29.
go back to reference Smyth DJ, Cooper JD, Bailey R et al (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617–619PubMedCrossRef Smyth DJ, Cooper JD, Bailey R et al (2006) A genome-wide association study of nonsynonymous SNPs identifies a type 1 diabetes locus in the interferon-induced helicase (IFIH1) region. Nat Genet 38:617–619PubMedCrossRef
30.
go back to reference Crampton SP, Deane JA, Feigenbaum L, Bolland S (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188:1451–1459PubMedCrossRef Crampton SP, Deane JA, Feigenbaum L, Bolland S (2012) Ifih1 gene dose effect reveals MDA5-mediated chronic type I IFN gene signature, viral resistance, and accelerated autoimmunity. J Immunol 188:1451–1459PubMedCrossRef
31.
go back to reference Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84:6272–6276PubMedCrossRef Kandolf R, Ameis D, Kirschner P, Canu A, Hofschneider PH (1987) In situ detection of enteroviral genomes in myocardial cells by nucleic acid hybridization: an approach to the diagnosis of viral heart disease. Proc Natl Acad Sci U S A 84:6272–6276PubMedCrossRef
32.
go back to reference Harkonen T, Puolakkainen M, Sarvas M, Airaksinen U, Hovi T, Roivainen M (2000) Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol 62:383–391PubMedCrossRef Harkonen T, Puolakkainen M, Sarvas M, Airaksinen U, Hovi T, Roivainen M (2000) Picornavirus proteins share antigenic determinants with heat shock proteins 60/65. J Med Virol 62:383–391PubMedCrossRef
33.
go back to reference Harkonen T, Lankinen H, Davydova B, Hovi T, Roivainen M (2002) Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 66:340–350PubMedCrossRef Harkonen T, Lankinen H, Davydova B, Hovi T, Roivainen M (2002) Enterovirus infection can induce immune responses that cross-react with beta-cell autoantigen tyrosine phosphatase IA-2/IAR. J Med Virol 66:340–350PubMedCrossRef
Metadata
Title
No evidence of enteroviruses in the intestine of patients with type 1 diabetes
Authors
A. Mercalli
V. Lampasona
K. Klingel
L. Albarello
C. Lombardoni
J. Ekström
V. Sordi
A. Bolla
A. Mariani
D. Bzhalava
J. Dillner
M. Roivainen
E. Bosi
L. Piemonti
Publication date
01-09-2012
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 9/2012
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-012-2591-4

Other articles of this Issue 9/2012

Diabetologia 9/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.